54277 studies found for:    Open Studies
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Monocentric Registry to Investigate the Role of Platelet Function, Platelet Pharmacogenomics, Proteomics and Metabonomics in Ischemic and Non-ischemic Heart Disease
Condition: Cardiovascular Disease
Intervention:
2 Recruiting Cortisol and Nutritional Sympathetic Responsiveness
Conditions: Metabolic Syndrome;   Obesity;   Insulin Resistance
Interventions: Drug: metyrapone;   Drug: placebo
3 Recruiting Lenalidomide After Donor Stem Cell Transplant and Bortezomib in Treating Patients With High Risk Multiple Myeloma
Conditions: Refractory Multiple Myeloma;   Stage I Multiple Myeloma;   Stage II Multiple Myeloma;   Stage III Multiple Myeloma
Interventions: Drug: fludarabine phosphate;   Radiation: total-body irradiation;   Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation;   Drug: cyclosporine;   Drug: mycophenolate mofetil;   Drug: bortezomib;   Drug: lenalidomide;   Other: laboratory biomarker analysis
4 Recruiting PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Salivary Gland Cancer;   Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Nasopharynx;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Verrucous Carcinoma of the Larynx;   Recurrent Verrucous Carcinoma of the Oral Cavity;   Salivary Gland Squamous Cell Carcinoma;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Nasopharynx;   Stage IVA Salivary Gland Cancer;   Stage IVA Squamous Cell Carcinoma of the Larynx;   Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVA Verrucous Carcinoma of the Larynx;   Stage IVA Verrucous Carcinoma of the Oral Cavity;   Stage IVB Salivary Gland Cancer;   Stage IVB Squamous Cell Carcinoma of the Larynx;   Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVB Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVB Verrucous Carcinoma of the Larynx;   Stage IVB Verrucous Carcinoma of the Oral Cavity;   Stage IVC Salivary Gland Cancer;   Stage IVC Squamous Cell Carcinoma of the Larynx;   Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVC Squamous Cell Carcinoma of the Oropharynx;   Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVC Verrucous Carcinoma of the Larynx;   Stage IVC Verrucous Carcinoma of the Oral Cavity;   Tongue Cancer
Interventions: Drug: PI3K inhibitor BKM120;   Biological: cetuximab;   Other: laboratory biomarker analysis;   Other: questionnaire administration
5 Unknown  Adderall XR and Processing Speed in Multiple Sclerosis (MS)
Conditions: Impaired Processing Speed;   Cognitive Impairment;   Multiple Sclerosis
Interventions: Drug: Adderall XR 5mg;   Drug: Adderall XR 10 mg;   Drug: Placebo
6 Not yet recruiting Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery
Conditions: Recurrent Bladder Cancer;   Stage I Bladder Cancer;   Stage II Bladder Cancer;   Stage III Bladder Cancer
Interventions: Drug: erlotinib hydrochloride;   Other: placebo;   Procedure: therapeutic conventional surgery;   Other: pharmacological study;   Other: laboratory biomarker analysis
7 Recruiting Role of a Combination of Nutraceuticals (Ritmonutra) on Benign Supraventricular and Ventricular Arrhythmias
Condition: Ventricular and Atrial Extrasytoles
Interventions: Dietary Supplement: Ritmonutra;   Dietary Supplement: placebo
8 Recruiting Comparing Maximal and Half-maximal Suction Pressure Applied During Water Exchange in Colonoscopy
Condition: Minimally Sedated Patient Undergoing Colonoscopy
Interventions: Procedure: half-maximal pressure;   Procedure: maximal pressure;   Device: Suction Unit
9 Recruiting Mechanisms of Pharyngeal Collapse in Sleep Apnea, Study D
Condition: Sleep Apnea
Intervention: Other: Induced central apneas
10 Unknown  Bronchial Inflammation in Patients With Severe Immune Deficiency Under Immunoglobulin Treatment
Condition: Immune Deficiency
Intervention:
11 Unknown  Immune Thrombocytopenia (ITP) Immune-Genetic Assessment
Condition: Thrombocytopenia
Intervention:
12 Recruiting Targeted Ultrasound in Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis;   Targeted Ultrasound
Intervention: Drug: Adalimumab
13 Recruiting Study of Nasal Airflow Pressure Optimization to Resolve Excessive Snoring
Condition: Habitual, Simple Snoring
Intervention: Device: nasal continuous positive airway pressure less than or equal to 6 cm H2O
14 Recruiting Prospective, Non-randomized, Safety and Efficacy Study of a New Occluder Design for Minimally Invasive Closure of the Left Atrial Appendage (LAA) in Patients With Atrial Fibrillation
Condition: Atrial Fibrillation
Intervention: Device: Implantation of LAA closure device
15 Not yet recruiting A Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lung Cancer
Condition: Lung Cancer in Normal and Malignant Tumors
Intervention: Drug: ALA-induced Fluorescence
16 Recruiting Community Intervention to Prevent Nipah Spillover
Condition: Human NiV Infection
Interventions: Behavioral: Ask people not to drink raw sap;   Behavioral: Ask people not to drink sap or drink sap from skirt protected trees;   Other: No Intervention
17 Recruiting Type 1 Diabetes Mellitus Effect on Bone Mineral Density
Conditions: Diabetes Mellitus;   Osteoporosis
Intervention:
18 Recruiting Oocyte Survival After Vitrification in an Open or Closed Device With Closed Storage.
Condition: Survival
Interventions: Device: CBSvit HS device;   Device: Cryotop SC device
19 Unknown  The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus
Condition: Discoid Lupus Erythematosus (DLE)
Intervention: Drug: etanercept(Enbrel®)
20 Unknown  Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration
Condition: Macular Degeneration
Interventions: Drug: Microplasmin;   Drug: Placebo control

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years